Standard therapy for the treatment of malignant pleural mesothelioma

Lung Cancer

Volumn 50, Issue SUPPL. 1, 2005, Pages

  Vogelzang, Nicholas J ^a  

^a NEVADA CANCER INSTITUTE   (United States)

Author keywords

Antimetabolite; Malignant pleural mesothelioma; Pemetrexed; Thoracic cancer

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; CYANOCOBALAMIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; FOLIC ACID; GEFITINIB; GEMCITABINE; HISTONE DEACETYLASE INHIBITOR; PEMETREXED; RALTITREXED; VASCULOTROPIN INHIBITOR; VATALANIB;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG CYTOTOXICITY; HUMAN; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SIDE EFFECT; STANDARDIZATION; SURVIVAL TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CLINICAL TRIALS, PHASE II; GLUTAMATES; GUANINE; HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 27744476091     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(05)81557-0     Document Type: Article

References (7)

1. Thödtmann R, Depenbrock H, and Dumez H Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin J Clin Oncol 17 1999 3009 3016
2. Hughes A, Calvert P, and Azzabi A Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma J Clin Oncol 20 2002 3533 3544
3. 12 as front-line therapy in malignant pleural mesothelioma J Clin Oncol 21 2003 1556 1561
4. Shepherd FA, Dancey J, and Arnold A Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group Cancer 92 2001 595 600
5. Vogelzang NK, Rusthoven JJ, and Symanowski J Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 2003 2636 2644
6. Abstract 7021 Van Meerbeeck JP, Manegold C, and Gaafar R A randomized phase III study of cisplatin with or without raltitrexed in patients (pts) with malignant pleural mesothelioma (MPM): an intergroup study of the EORTC Lung Cancer Group and NCIC Am Soc Clin Oncol 2004
7. Manegold C, Symanowski J, and Gatzemeier U Secondline (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma Ann Oncol 16 2005 923 927